Finally, the last study identified from the literature search [28] was a randomized, placebo-controlled, crossover study in 28 patients with bvFTD or a semantic variant of primary progressive aphasia (PPA) with social behavioral disorders who received a single dose of 72 IU intranasal oxytocin. This evidence concerns the gene OXT and primary progressive aphasia.